<DOC>
	<DOCNO>NCT00668187</DOCNO>
	<brief_summary>Hypothesis : To characterize describe disease progression heterogeneity gangliosidosis diseases . This research study seek develop quantitative method delineate disease progression gangliosidosis disease ( Tay-Sachs disease , Sandhoff disease , GM1 gangliosidosis ) order well understand natural history heterogeneity disease . Such quantitative method also essential evaluate treatment may become available future , gene therapy . The data study necessary provide end-points future therapy , guide medical decision treatment , provide objective measurement treatment outcome , accurately inform parent regard potential outcome .</brief_summary>
	<brief_title>A Natural History Study Gangliosidoses</brief_title>
	<detailed_description>The infantile form GM2 GM1 gangliosidosis disease ( `` classic '' infantile ) common . Infants Tay-Sachs disease , Sandhoff disease GM1 gangliosidosis appear normal birth , approximately 6-10 month age begin manifest progressive weakness loss muscle strength , loss ability sit turn . They may evidence deafness , display decrease attentiveness . This follow rapid deterioration motor skill slow mental development ( neurodegeneration ) , often seizures . Retinal involvement lead visual impairment eventual blindness . Death typically occur age five . Currently treatment Tay-Sachs disease , Sandhoff disease GM1 gangliosidosis . Late Onset Tay-Sachs disease ( `` LOTS '' ) occur patient begin twenty thirty , characterize poor motor coordination psychotic behavior . Patients LOTS also decrease life expectancy , although less degree infantile juvenile Tay-Sachs Sandhoff disease . Currently treatment LOTS . This study comprise two different 'arms . ' The first arm , entitle Aim 1 , focus developmental course infantile juvenile Tay-Sachs disease , Sandhoff disease , GM1 gangliosidosis . Longitudinal data individual disease collect order delineate natural history disease . This data help objectify disease progression , use create disease stage severity index . The second arm , entitle Aim 2 , focus LOTS seek understand progression central nervous system disease , special focus upon cerebellar frontal system . This accomplish use quantitative method include neuroimaging neuropsychological measure explore motor executive function , visual-spatial emotional-behavioral dysfunction .</detailed_description>
	<mesh_term>Gangliosidoses</mesh_term>
	<mesh_term>Tay-Sachs Disease</mesh_term>
	<mesh_term>Sandhoff Disease</mesh_term>
	<mesh_term>Gangliosidoses , GM2</mesh_term>
	<mesh_term>Gangliosidosis , GM1</mesh_term>
	<criteria>1 . Subjects must document gangliosidosis disease . 2 . Subjects must able complete appropriate neuropsychological neurobehavioral assessment . 3 . Lateonset gangliosidosis subject must able tolerate head MRI . 1 . There exclusion criterion , beyond desire participate .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Tay-Sachs disease</keyword>
	<keyword>Sandhoff disease</keyword>
	<keyword>Late Onset Tay-Sachs disease</keyword>
	<keyword>LOTS</keyword>
	<keyword>hexosaminidase A deficiency</keyword>
	<keyword>hexosaminidase A B deficiency</keyword>
	<keyword>infantile Tay-Sachs disease</keyword>
	<keyword>adult-onset Tay-Sachs disease</keyword>
	<keyword>prospective</keyword>
	<keyword>natural history</keyword>
	<keyword>GM1 gangliosidosis</keyword>
	<keyword>gangliosidoses</keyword>
	<keyword>β-galactosidase</keyword>
	<keyword>β-galactosidase deficiency</keyword>
	<keyword>hexosaminidase</keyword>
	<keyword>hexosaminidase deficiency</keyword>
	<keyword>Tay-Sachs</keyword>
	<keyword>Sandhoff</keyword>
	<keyword>juvenile Tay-Sachs</keyword>
	<keyword>juvenile Tay-Sachs disease</keyword>
	<keyword>late onset Tay-Sachs</keyword>
	<keyword>juvenile Sandhoff</keyword>
	<keyword>juvenile Sandhoff disease</keyword>
	<keyword>GM2 gangliosidosis</keyword>
</DOC>